191 related articles for article (PubMed ID: 35574600)
1. Identification of SAA1 as a prognostic biomarker associated with immune infiltration in glioblastoma.
Cui G; Xiao Y
Autoimmunity; 2022 Sep; 55(6):418-427. PubMed ID: 35574600
[TBL] [Abstract][Full Text] [Related]
2. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
Cao K; Jiang X; Wang B; Ni Z; Chen Y
Front Neurol; 2022; 13():905561. PubMed ID: 35756918
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel prognostic targets in glioblastoma using bioinformatics analysis.
Yin X; Wu Q; Hao Z; Chen L
Biomed Eng Online; 2022 Apr; 21(1):26. PubMed ID: 35436915
[TBL] [Abstract][Full Text] [Related]
5. SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma.
Xu Z; Wu Y; Fu G; Chen X; Sun J; Tian J; Jiang P; Wang Y; Jin B
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108666
[TBL] [Abstract][Full Text] [Related]
6. Serum amyloid A1 in combination with integrin αVβ3 increases glioblastoma cells mobility and progression.
Lin CY; Yang ST; Shen SC; Hsieh YC; Hsu FT; Chen CY; Chiang YH; Chuang JY; Chen KY; Hsu TI; Leong WC; Su YK; Lo WL; Yeh YS; Patria YN; Shih HM; Chang CC; Chou SY
Mol Oncol; 2018 May; 12(5):756-771. PubMed ID: 29603594
[TBL] [Abstract][Full Text] [Related]
7. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
Tian QS; Zhang Q; Huang W
Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
[TBL] [Abstract][Full Text] [Related]
8. [Single-cell transcriptome analysis of multigrade glioma heterogeneity and immune microenvironment revealed potential prognostic biomarkers].
Liu J; Xu K; Ma L; Wang Y
Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3790-3808. PubMed ID: 36305410
[TBL] [Abstract][Full Text] [Related]
9. Prediction and analysis of hub genes between glioblastoma and low-grade glioma using bioinformatics analysis.
Xu B
Medicine (Baltimore); 2021 Jan; 100(3):e23513. PubMed ID: 33545929
[TBL] [Abstract][Full Text] [Related]
10. A 63 signature genes prediction system is effective for glioblastoma prognosis.
Zhang Y; Xu J; Zhu X
Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370
[TBL] [Abstract][Full Text] [Related]
11. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
13. Microrna-1224-5p Is a Potential Prognostic and Therapeutic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Analyses.
Wei X; Zhang QM; Liu C; Wu S; Nong WX; Ge YY; Lin LN; Li F; Xie XX; Luo B
Curr Med Sci; 2022 Jun; 42(3):584-596. PubMed ID: 35678909
[TBL] [Abstract][Full Text] [Related]
14. PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma.
Dong C; Fan W; Fang S
J Mol Neurosci; 2020 Jan; 70(1):56-64. PubMed ID: 31617063
[TBL] [Abstract][Full Text] [Related]
15. Multi-omics analysis predicts fibronectin 1 as a prognostic biomarker in glioblastoma multiforme.
Kabir F; Apu MNH
Genomics; 2022 May; 114(3):110378. PubMed ID: 35513291
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the key prognostic genes and potential traditional Chinese medicine therapeutic targets in glioblastoma based on bioinformatics and network pharmacology methods.
Xia Z; Gao P; Chen Y; Shu L; Ye L; Cheng H; Dai X; Hu Y; Wang Z
Transl Cancer Res; 2022 May; 11(5):1386-1405. PubMed ID: 35706800
[TBL] [Abstract][Full Text] [Related]
17. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis.
Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
19. Identification of gene biomarkers and immune cell infiltration characteristics in rectal cancer.
Wen L; Han Z; Du Y
J Gastrointest Oncol; 2021 Jun; 12(3):964-980. PubMed ID: 34295549
[TBL] [Abstract][Full Text] [Related]
20. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]